Commercial Space Company Risk / Opportunity Ranking

Thesis: The reviewed sources' membership rationale says Orbitworks is an Abu Dhabi satellite integrator planning a 50-satellite AI-powered Earth observation constellation and participating in a SAR satellite program. If accurate and current, that implies meaningful long-horizon platform and constellation buildout opportunity, but the reviewed sources lack direct supporting summaries or available evidence.

Why now: The rationale references growth-oriented planned activity, which is relevant to a 1 year+ horizon, yet timing confidence is limited because coverage data shows no evidence after recent evidence window.

Caveats: Membership rationale references article IDs, and: but and article summaries are not provided in the reviewed sources. No direct positive_evidence or negative_evidence arrays are populated. Opportunity is based on stated plans, not validated conversion, contracts, or operating milestones inside the recent evidence window.

Thesis: Reviewed evidence rationale says Overview Energy won a U.S. Air Force contract for orbit-to-grid energy technology using geosynchronous satellites and space-based solar power. A defense contract in an ambitious emerging category is positive for strategic validation over a 1 year+ horizon.

Why now: The likely catalyst is the reported Air Force contract, yet the reviewed sources gives no retained article summary or evidence row to establish recency or contract scale.

Caveats: Phase2 membership rationale references: but no article summary or evidence are available. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0.

Thesis: Reviewed evidence context says Pacific Defense launched the Moonraker payload, described as the first on-orbit demo of a reprogrammable payload for SSA/EMSO, developed under an AFRL contract. An on-orbit demo tied to a government contract is stronger business progress context than most peers in this screen and could support longer-horizon defense-space opportunity if follow-on adoption occurs.

Why now: The company appears more advanced than several peers because the reviewed sources references an on-orbit demo under contract, but there is no citable recency signal beyond membership support article ID: and no available evidence after recent evidence window.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary for citation. Opportunity score is relative within a weak-evidence batch, not high absolute conviction.

Thesis: Reviewed evidence rationale says Portal Space Systems raised a $50M Series A and offers commercial debris removal as a service with its Starburst spacecraft, which is directionally positive for a long-horizon growth thesis if validated.

Why now: Potential why-now would be the reported Series A and service positioning, but recency cannot be verified because no evidence are retained after the recent evidence window.

Caveats: Phase2 membership rationale references: but no article summary or evidence are included. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Slightly higher opportunity than some peers only because the reviewed sources rationale mentions both financing and product/service positioning.

Thesis: QOSMIC has some opportunity potential because reviewed sources context says it raised about $3.3 million in seed funding to build optical communications infrastructure for space, with proceeds intended for engineering expansion, manufacturing scale-up, and deployment of optical communication terminals. That indicates an early-stage capital infusion tied to product buildout, but the evidence is undated and article-level rather than direct dated event evidence.

Why now: Why now is weak because the only support is undated context articles; the reviewed sources explicitly says no is available, so recency-sensitive claims should be treated cautiously for these funding and expansion statements

Caveats: Evidence is undated; recency is uncertain. Support is supporting article context only, not direct structured positive event evidence. Same funding story appears in two articles and should not be treated as independent confirmation.

Thesis: The reviewed sources membership rationale says Quantum Space was selected by the U.S. Space Force for the Andromeda space monitoring satellite program. If current and material, that indicates credible government-program positioning in a strategically durable market.

Why now: The reviewed sources provide no post-recent evidence window detailed evidence, but the membership rationale specifically references selection for the Andromeda program via article. Because the underlying article summary/ is not included here, timing and magnitude are uncertain.

Caveats: No representative article or is included for the cited Andromeda selection evidence. Selection for a program is positive, but without award size or timing the business impact is unclear. Scores are capped by missing direct article-level support.

Thesis: Sierra Nevada Corporation has the strongest available reviewed sources signal because a within the recent evidence window article says Space Systems Command awarded more than $1.8 billion in Andromeda contracts and included Sierra Space among the awarded companies, indicating participation in a potentially durable U.S. national-security space program if the Sierra Space/Sierra Nevada linkage holds.

Why now: The key surviving context is dated April 8, 2026, within the 90-day recent evidence window, and references recent contract awards under Andromeda that could matter over a 1 year+ horizon if they convert into meaningful program work. Article timestamp: April 8, 2026, basis: source date. Evidence is from at

Caveats: Evidence is supporting article context, not a direct structured positive event row for Sierra Nevada Corporation. Reviewed evidence explicitly notes entity-resolution ambiguity between Sierra Nevada Corporation and Sierra Space. The second representative article is older than the 90-day recent evidence window and should not drive recency, published September 2, 2025.

Thesis: Reviewed evidence context says SpinLaunch's Meridian Space broadband constellation has 280 satellites being built. If accurate and current, that implies a tangible manufacturing/program buildout that could become strategically meaningful over a 1 year+ horizon.

Why now: There is no direct, dated catalyst in the available evidence. The reviewed sources references article ID: for membership support, but provides no and shows 0 evidence after recent evidence window, so current status cannot be verified.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources does not include a or summary for citation.

Thesis: Starcloud has the strongest relative opportunity case in this screen, albeit still low-conviction, because the reviewed sources' membership rationale references a reported $170M Series A and orbital AI/data-center activity. For a 1 year+ horizon, fundraising plus infrastructure ambition could matter if execution follows, but the reviewed sources provide no direct positive evidence, no, and no validated chronology inside the recent evidence window.

Why now: If the fundraising and product positioning are recent, they could support a multi-quarter buildout story, but the reviewed sources explicitly shows zero available evidence after recent evidence window, so recency and sequencing cannot be confirmed.

Caveats: Most supportive facts appear only in membership rationale, not available evidence. Reported funding cannot be treated as fully validated without direct article support in reviewed sources. No, quote, or dated direct summary is available.

Thesis: Stelleo has some opportunity appeal because recent company-context evidence positions it as a Polish Earth Observation startup turning satellite intelligence into operational decisions for infrastructure, agriculture, and environmental users across Europe, suggesting a commercially relevant application layer.

Why now: The article is within the recent evidence window and dated May 25, 2026, but it is a company-site style description rather than an independently reported business event, so it supports relevance more than momentum

Caveats: Evidence is article-level company context, not a direct commercial milestone. No direct traction, financing, or contract evidence is provided. Same-article repeated rows are not independent confirmation.

Thesis: ThinkOrbital has a speculative long-horizon opportunity signal because a dated May 2026 company-context article describes products spanning space domain awareness and in-space servicing, including ThinkX and a robotic arm/end effector. That suggests exposure to strategically important capability areas if the products convert into funded programs.

Why now: Why now is the dated company-context article from May 28, 2026, recent within the recent evidence window, but it is still weak grounding because it is article-level website context rather than a confirmed business event.

Caveats: Evidence is article-level website context, not direct contract or financing evidence. Single-source evidence limits corroboration. No dated proof of revenue, customer adoption, or deployment is included.

Thesis: Viasat has modest opportunity support from recent supporting article context showing it was selected as a prime contractor in the U.S. Space Force Protected Tactical Satcom-Global program and that Rocket Lab will supply the spacecraft bus for Viasat's PTS-G satellite, indicating active participation in a next-generation military satcom program.

Why now: Recent context exists within the recent evidence window: is dated June 11, 2026 and states Viasat was among operators selected under a combined $437.7 million award and has a defined supplier stack for its PTS-G satellite, which could matter over a 1 year+ horizon. Source date basis is source date.

Caveats: This is supporting article context only; the reviewed sources classifies it under weak context, so it is weaker than direct event/fact evidence. Same article appears in two weak-context rows and should not be treated as independent confirmation. An older Viasat company-hosted article exists but is outside recent evidence window, February 29, 2024

Thesis: Volta Space Technologies has an interesting long-horizon speculative opportunity because the reviewed sources rationale says it is developing a lunar laser power transmission system, with a 2028 demonstration planned and a payload booked on Firefly's Blue Ghost Mission 2.

Why now: The rationale cites article and says the company has a 2028 demonstration planned with payload booked on Blue Ghost Mission 2, which is relevant to a 1 year+ strategic horizon but weak for immediate evidence-based ranking because no article body or is visible.

Caveats: No visible representative article, quote, or in the reviewed sources body. The main cited demonstration is scheduled for 2028, so commercial payoff may sit beyond the stated 1 year+ ranking horizon. The Firefly payload linkage cannot be used as counterparty propagation evidence beyond the explicit rationale.

Thesis: The membership rationale describes VyomIC as a Bengaluru-based New Space startup deploying a private global PNT satellite constellation in LEO, with first satellites planned for 2027 and 2028. That suggests large strategic upside over a 1 year+ horizon if financing and execution continue.

Why now: Why now is moderate only because the business is framed around future constellation deployment and milestone timing beyond the immediate term; however, recency cannot be validated because no recent evidence window evidence are available.

Caveats: Membership rationale cites article IDs and, but no are present. No representative article text or direct event/facts are available after the 90-day recent evidence window. Scoring reflects early-stage optionality and execution risk, not direct verified traction.

Thesis: Wyvern has a plausible long-term opportunity in hyperspectral Earth observation. The reviewed sources say the company launched commercial hyperspectral satellites in 2023 and claims to be the only commercial provider with a ready-to-task constellation, which, if current, suggests existing capacity and differentiated imagery access.

Why now: Why now is weak because the evidence retained is undated and the reviewed sources explicitly says to treat recency-sensitive claims cautiously when no is available. The underlying strategic area may be attractive, but current business-state confirmation is missing.

Caveats: Evidence is undated, so current-state claims are less reliable for timing judgments. Only supporting article context is provided, not direct event evidence. No direct customer, contract, financing, or negative-event evidence is shown.

Thesis: Membership rationale says AAC Clyde Space signed a EUR 10.9 million ESA contract for a 12-satellite VDES constellation, which would be meaningful positive evidence for a 1 year+ horizon if directly available, but these reviewed sources provide no surviving evidence or article summaries to substantiate the current state beyond the rationale reference (: unavailable in reviewed sources).

Why now: Why now is weak because the reviewed sources' recent evidence review and coverage data show zero available evidence after recent evidence window despite the membership rationale referencing a material contract.

Caveats: No current evidence is provided for Contract claim appears only in membership rationale, not in available direct evidence fields. No recency-confirmed follow-through evidence is available.

Thesis: Agnikul appears to have credible long-horizon opportunity potential because the reviewed sources places it among Indian spacetech beneficiaries and identifies it as 'launch infrastructure' in one summary, suggesting sector exposure that could matter over a year-plus horizon if operating milestones follow.

Why now: The only timing argument is broad strategic sector positioning in Indian spacetech; there is no validated current catalyst in available evidence.

Caveats: Phase-2 rationale references: and: but the reviewed sources does not provide or summaries. Sector beneficiary framing is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window.

Thesis: Arctus Aerospace has a modestly better long-horizon opportunity case than most peers in this screen because the reviewed sources rationale states it raised $2.6M and is developing HALE UAVs for earth observation, indicating financing plus product development progress (: no provided in reviewed sources).

Why now: Funding plus ongoing development could matter over a 1 year+ horizon, but there is no retained dated evidence row to confirm timing, financing close date, or development milestone sequence.

Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The positive case relies on phase2 rationale rather than retained direct event/facts.

Thesis: Reviewed evidence membership rationale says Astrolab received NASA moon-base/lunar-terrain-vehicle related contract support, which could be favorable over a 1 year+ horizon if active, but no available article evidence remains to support a stronger current ranking.

Why now: Why-now support is weak because coverage data shows no evidence after recent evidence window, so the cited lunar contract context cannot be refreshed from available evidence.

Caveats: Phase2 rationale cites, and: but no representative article or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Private-company watch item rather than high-conviction ranked candidate.

Thesis: Membership rationale states Axelspace is launching seven GRUS-3 Earth observation microsatellites and expanding its constellation to more than 10 satellites, which would support an opportunity thesis tied to capacity expansion, but no direct evidence or article summaries are available in the reviewed sources after recent evidence window (: unavailable in reviewed sources).

Why now: Why now is weak because the reviewed sources references a potentially important constellation expansion but provides no post-recent evidence window available evidence to confirm status or timing.

Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Recency of constellation expansion cannot be validated from reviewed sources fields.

Thesis: No direct negative evidence is retained in the reviewed sources for KVH Industries within the selected recent evidence window.

Why now: The membership rationale says KVH appeared as a listed player in a generic defense satellite communication market report tied to article: but the reviewed sources retains zero evidence after recent evidence window and provides no, so this is too weak for a directional thesis.

Caveats: Generic market-report mention is weaker than company-specific event evidence. The support article ID is cited in the reviewed sources rationale but no article or retained evidence row is provided.

Thesis: No material adverse evidence is available. The low risk score should be interpreted as insufficient evidence, not affirmative de-risking.

Why now: Why-now is weak because no within the recent evidence window evidence are available, so timing, financing status, and launch progress cannot be judged from the current reviewed sources.

Caveats: Membership rationale references, and, but no article details are available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Potential IPO/funding relevance is mentioned only in membership rationale and cannot be elevated without direct evidence.

Thesis: No direct negative evidence is available in the reviewed sources, so no risk thesis is supportable.

Why now: The reviewed sources only describes that Intuitive Machines acquired Lanteris for about $800M via article, but provides no available evidence, no business description, and no.

Caveats: Acquisition mention without business detail is insufficient for ranking direction. No post-recent evidence window evidence are available. Referenced has no in the reviewed sources.

Thesis: No direct adverse evidence is available in the reviewed sources, and the main limitation is that Leidos appears to be a defense IT contractor rather than a core commercial space operator under these cohort rules.

Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources.

Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics.

Thesis: The reviewed sources does not provide direct negative evidence on LeoLabs in the available recent evidence window period, so risk scoring remains low.

Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources.

Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score.

Thesis: No retained adverse evidence exists in the active recent evidence window, so only a low risk score is supportable from these reviewed sources.

Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis.

Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence.

Thesis: No retained adverse evidence is shown, so a negative thesis is likewise unsupported.

Why now: Why now is weak because 8 articles were considered but zero remained after the March 29, 2026 cutoff, leaving no current catalyst or status confirmation.

Caveats: No recent evidence window-qualified evidence. Phase-2 rationale is not enough for directional conviction.

Thesis: Insufficient retained evidence within the reviewed sources to support a material adverse thesis.

Why now: There is no available post-recent evidence window evidence for this company. The reviewed sources notes two considered articles, but zero article IDs after recent evidence window and zero evidence retained, so recency-sensitive judgment is not possible.

Caveats: The reviewed sources say support used article IDs existed earlier, but no retained evidence are available after the 90-day recent evidence window cutoff of March 29, 2026. Absence of evidence is not positive or negative proof.

Thesis: There is no direct adverse evidence in the reviewed sources; the main risk is that evidence is context-only and insufficient to assess business traction or downside.

Why now: No dated or citable event evidence is available. The reviewed sources indicates provisional single-article context tied to article id: but no or summary is provided and no evidence survived recent evidence window.

Caveats: Support level is explicitly provisional_single_article_context, which is weaker than company-specific event or fact evidence. No current evidence is provided for article: preventing direct citation. Scores remain minimal due to lack of evidence, not a strong negative view.

Thesis: No material adverse evidence is available in the reviewed sources.

Why now: There is no retained post-recent evidence window evidence row in these reviewed sources despite membership rationale referencing NASA-related wins, so timing support is insufficient.

Caveats: Membership rationale is not enough for a strong thesis without cited retained evidence. Coverage after recent evidence window is effectively zero in these reviewed sources.

Thesis: There is no direct adverse evidence in the reviewed sources within the recent evidence window; risk is scored low because the reviewed sources are evidence-empty rather than because the business is de-risked.

Why now: No within the recent evidence window company-specific catalyst or business-state change is available. Coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window, with cutoff date March 29, 2026.

Caveats: Reviewed evidence references only a profile-like article via membership rationale, not available direct evidence: but no is provided in these reviewed sources. No current source-cited evidence was found in the reviewed sources.

Thesis: There is no material adverse evidence available after recent evidence filtering; the main risk is that the company's actual role and relevance cannot be established from reviewed sources evidence.

Why now: No direct catalyst or citable business-state evidence is available. The reviewed sources references article ids: and: but provides no and no retained evidence.

Caveats: The reviewed sources explicitly says the evidence is mostly thematic/stock-basket context rather than direct business description. No or quotes are provided for direct citation.

Thesis: No material adverse thesis is supportable from the retained evidence in these reviewed sources. The low risk score reflects lack of evidence, not business quality.

Why now: Why now is weak because the reviewed sources' evidence recent evidence review shows zero kept rows after the 90-day cutoff ending March 29, 2026 and coverage data shows articles after recent evidence window of 0, so recency is not established from retained evidence.

Caveats: Phase-2 membership rationale cites but no or retained evidence row is provided in these reviewed sources, so it cannot be used for factual claims. Coverage after recent evidence window is effectively empty: evidence recent evidence review cutoff_date March 29, 2026 with kept_rows 0. Scores reflect insufficient evidence, not a fundamental bearish or bullish view.

Thesis: No material adverse thesis is supportable from the retained evidence.

Why now: Why now is weak because no evidence survived the 90-day recent evidence window in the available reviewed sources; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: Phase-2 rationale is not enough for a factual claim without and retained evidence detail. No within the recent evidence window direct evidence is available. Low scores reflect absence of usable evidence.

Thesis: No retained 90-day direct negative evidence is available to support a risk thesis.

Why now: The reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent company-specific evidence base for a 1 year+ directional call.

Caveats: Historical membership support references article IDs, but no post-recent evidence window evidence are served here. Low scores reflect insufficient evidence, not an evaluated business conclusion.

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Marlan Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Partnership context alone should not be treated as propagated operating evidence under the evidence standard.

Thesis: No material negative evidence is available; the main risk is lack of current reviewed sources evidence and classification as a supplier rather than a core space operator.

Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources.

Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window.

Thesis: No adverse evidence is present. Risk stays low because there is no material negative event in the reviewed sources.

Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields.

Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence.

Thesis: There is also insufficient direct adverse evidence; the main risk is simply that the reviewed sources' support is generic and not company-event-specific, preventing a meaningful thesis ranking.

Why now: No 'why now' is evidenced. The reviewed sources show zero post-recent evidence window available evidence despite a large article universe.

Caveats: Phase-2 rationale references: but no or summary is provided. Generic market-report mention is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window.

Thesis: No retained direct negative evidence is provided, so the reviewed sources does not support a material adverse thesis either.

Why now: Why now is weak because despite 72 articles considered, zero article IDs and zero evidence were retained after the March 29, 2026 cutoff, preventing any current sequencing or catalyst assessment.

Caveats: No admissible post-recent evidence window evidence. Membership review rationale is contextual only and not a directional scoring basis by itself.